Circassia Pharmaceuticals plc
Total Voting Rights Update
11 June 2015
In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1A, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that, following admission earlier today of 95,469,537 new ordinary shares of 0.08P each to the official list and to trading on the main market for listed securities of the London Stock Exchange, the Company's issued share capital consists of 284,889,171 ordinary shares in issue, each with equal voting rights. No shares are held in treasury.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.
-Ends-
For further information, please contact: |
|
Circassia Pharmaceuticals plc Julien Cotta, Company Secretary |
+44 (0) 1865 405560 |